NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NRJun Yoshino, Shin‐ichiro Imai, Joseph A. Baur|Cell Metabolism|2017Cited by 1k
Rapalogs and mTOR inhibitors as anti-aging therapeuticsDudley W. Lamming, Joseph A. Baur|Journal of Clinical Investigation|2013Cited by 536
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of ResveratrolOle Vang, Joseph Wu, Nihal Ahmad et al.|PLoS ONE|2011Cited by 437
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in MiceSarah J. Mitchell, Rafael de Cabo, Michel Bernier et al.|Cell Metabolism|2018Cited by 332
SLC25A51 is a mammalian mitochondrial NAD+ transporterTimothy S. Luongo, Joseph A. Baur, Jared Eller et al.|Nature|2020Cited by 301